SELUTION4SFA Trial (NCT05132361)
A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Efficacy of the SELUTION SLR™ 018 Drug Eluting Balloon in the Treatment of Subjects With Femoropopliteal Artery Lesions
🩺 Plain-English Summary (8th-Grade Level)
This study aims to demonstrate the safety and efficacy of the SELUTION SLR™ 018 DEB compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
Who can join: Review the eligibility criteria below.
Location: Arkansas Heart Hospital — Little Rock, Arkansas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (38 Sites)
Showing the first 25 of 38 sites.
- Arkansas Heart Hospital — Little Rock, Arkansas
- Mission Cardiovascular Research Institute — Fremont, California
- St. Helena Hospital — St. Helena, California
- ClinRé — Thornton, Colorado
- Vascular Care Group — Darien, Connecticut
- Manatee Memorial Hospital — Bradenton, Florida
- The Cardiac and Vascular Institute Research Foundation — Gainesville, Florida
- Memorial Healthcare System — Hollywood, Florida
- First Coast Cardiovascular Institute — Jacksonville, Florida
- Palm Vascular Centers — Miami Beach, Florida
- Guardian Research Organization, LLC — Winter Park, Florida
- Emory University Hospital — Atlanta, Georgia
- Cardiovascular Consultants of South Georgia — Thomasville, Georgia
- Heart Care Centers Research Foundation — Palos Park, Illinois
- Advocate Lutheran General Hospital — Park Ridge, Illinois
- Cardiovascular Institute of the South — Gray, Louisiana
- MedStar Health Research Institute — Hyattsville, Maryland
- Mercy Hospital — St Louis, Missouri
- Holy Name Medical Center — Teaneck, New Jersey
- James J. Peters VA Medical Center — The Bronx, New York
- NC Heart and Vascular Research, LLC — Raleigh, North Carolina
- Cleveland Clinic — Cleveland, Ohio
- Miriam Hospital — Providence, Rhode Island
- Tennessee Center for Clinical Trials — Tullahoma, Tennessee
- El Paso Cardiology — El Paso, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peripheral Arterial Disease
- SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — New Haven, Connecticut
- A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND) — Birmingham, Alabama
- Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy — Indianapolis, Indiana
- FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease — Chicago, Illinois
- MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology — Omaha, Nebraska
Explore by condition: All Peripheral Arterial Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.